DUNAYEVICH EDUARDO 4
4 · Orexigen Therapeutics, Inc. · Filed Jan 28, 2009
Insider Transaction Report
Form 4
DUNAYEVICH EDUARDO
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2009-01-26+47,770→ 47,770 totalExercise: $4.03Exp: 2019-01-25→ Common Stock (47,770 underlying)
Footnotes (2)
- [F1]1/12th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of the reporting person?s service as an employee, director or consultant following 1/26/2009, so that all of the shares of the stock subject to the option shall be vested on 1/26/2010, subject to the reporting person?s continued service relationship (whether as an employee, or consultant) with the Company or any parent or subsidiary on each such date.
- [F2]Not applicable.